LIAISON® TSH-R Ab
Fully automated test for diagnosis and monitoring of Graves' Disease
The LIAISON® TSH-R Ab assay is standardized against the WHO 2nd International Standard NIBSC (Code 08/204).
Background
Support in the diagnosis of Graves' Disease, the most common autoimmune thyroid disorder, and monitoring patient therapy.
Graves’ Disease is the most common autoimmune thyroid disorder, accounting for approximately 60%-80%* of all hyperthyroidism cases. It affects 0,5% to 3%* of the general population. If left untreated, the disease can cause a range of complications, including cardiovascular, eye and skin problems, osteoporosis, and in severe cases, a life-threatening condition called thyroid or thyrotoxic storm. The LIAISON® TSH-R Ab assay enhances patient management by enabling effective monitoring of therapy in individuals with Graves’ Disease. It features a novel, double-bridge technology, sandwich assay, which significantly improves performances and reliability.
*The Endocrine Society: www.endocrine.org/our-community/advancing-endocrinology-and-public-health
How it works
LIAISON® TSH-R Ab is a two steps bridge sandwich for the detection of anti-TSH-R in chemiluminescence immunoassay. The antigens are based on human TSHR-261 domain linked to heterologous fusion proteins.
No need for specialized staff
The fully automated LIAISON® TSH-R Ab assay runs on the LIAISON® XL and LIAISON® XS chemiluminescence analyzers in any laboratory.
WHO 08/204 standardization
Standardized against the 2nd IS WHO 08/204, LIAISON® TSH-R Ab ensures consistent and reliable results.
High-quality, high efficiency
High performance and outstanding efficiency are ensured by the new TSH-R Ab sandwich method on both LIAISON® XL and XS platforms.
Why use LIAISON® TSH-R Ab
LIAISON® TSH-R Ab provides reliable results, standardized against the WHO 2nd International Standard for TRAb. It can be used with both serum and plasma samples, with a wide assay range of 0.140 to 40.0 IU/L. Available on the LIAISON® analyzer family.
Support in the diagnosis
LIAISON® TSH-R Ab is specifically developed to aid in the diagnosis and monitoring of patients with suspected Graves’ Disease.
Enhanced perfomance and reliability
LIAISON® TSH-R Ab features a novel, double-bridge technology, sandwich assay, which significantly improves performances and reliability.
To be used on
Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.
LIAISON® XL
Designed for large laboratories. Fuse the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation.
LIAISON® XS
A fully automated, easy-to-use benchtop analyzer. Maximize productivity with optimal cost management, no daily maintenance, straightforward integration, and the same capabilities as Diasorin’s high-throughput analyzers.
More details about our diagnostic solutions
Login to Dialog for additional resources
Login to our repository for instructions for use and user manuals, assay information, protocols and much more.
All the products in this family
Discover the range of specialty tests available